Evidence map›Paper›PMID 32040766›Full record

ArticleJournal of cardiovascular translational research2020

Acute In Vivo Functional Assessment of a Biodegradable Stentless Elastomeric Tricuspid Valve.

Garrett N Coyan, Lindemberg da Mota Silveira-Filho, Yasumoto Matsumura, Samuel K Luketich, William Katz, Vinay Badhwar, William R Wagner, Antonio D'Amore

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Melt Electrowriting of Complex 3D Anatomically Relevant Scaffolds.Frontiers in bioengineering and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Garrett N CoyanUniversity of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID 0000-0003-0889-1592
Lindemberg da Mota Silveira-FilhoMcGowan Institute for Regenerative Medicine, Bridgeside Point 2 Building, 450 Technology Dr., Suite 300, Pittsburgh, PA, 15219, USA.
Yasumoto MatsumuraMcGowan Institute for Regenerative Medicine, Bridgeside Point 2 Building, 450 Technology Dr., Suite 300, Pittsburgh, PA, 15219, USA.
Samuel K LuketichMcGowan Institute for Regenerative Medicine, Bridgeside Point 2 Building, 450 Technology Dr., Suite 300, Pittsburgh, PA, 15219, USA.
William KatzUniversity of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Vinay BadhwarMcGowan Institute for Regenerative Medicine, Bridgeside Point 2 Building, 450 Technology Dr., Suite 300, Pittsburgh, PA, 15219, USA.
William R WagnerMcGowan Institute for Regenerative Medicine, Bridgeside Point 2 Building, 450 Technology Dr., Suite 300, Pittsburgh, PA, 15219, USA.
Antonio D'AmoreMcGowan Institute for Regenerative Medicine, Bridgeside Point 2 Building, 450 Technology Dr., Suite 300, Pittsburgh, PA, 15219, USA. and78@pitt.edu.
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · USUniversity of Pittsburgh Medical Center · USWest Virginia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Degradable heart valves based on in situ tissue regeneration have been proposed as potentially durable and non-thrombogenic prosthetic alternatives. We evaluated the acute in vivo function, microstructure, mechanics, and thromboresistance of a stentless biodegradable tissue-engineered heart valve (TEHV) in the tricuspid position. Biomimetic stentless tricuspid valves were fabricated with poly(carbonate urethane)urea (PCUU) by double-component deposition (DCD) processing to mimic native valve mechanics and geometry. Five swine then underwent 24-h TEHV implantation in the tricuspid position. Echocardiography demonstrated good leaflet motion and no prolapse and trace to mild regurgitation in all but one animal. Histology revealed patches of proteinaceous deposits with no cellular uptake. SEM demonstrated retained scaffold microarchitecture with proteinaceous deposits but no platelet aggregation or thrombosis. Explanted PCUU leaflet thickness and mechanical anisotropy were comparable with native tricuspid leaflets. Bioinspired, elastomeric, stentless TEHVs fabricated by DCD were readily implantable and demonstrated good acute function in the tricuspid position.

Indexed as

Heart Valve ProsthesisAnimalsElastomersHeart Valve Prosthesis ImplantationHemodynamicsMaterials TestingModels, AnimalPolyurethanesProsthesis DesignSus scrofaTricuspid ValveTricuspid Valve InsufficiencyElastomerspoly(carbonate urea) urethanePolyurethanesBiodegradable valve prosthesisDouble-component depositionElectrospinningIn vivo studyTissue-engineered heart valveTricuspid valve replacement

Identifiers

PMID32040766
OpenAlexW3005950933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.